Reported about 1 year ago
U.S. Customs and Border Protection officers are seizing illegal shipments of the weight-loss drug Ozempic entering the United States through e-commerce channels. The shipments, originating from Colombia and destined for New York, Massachusetts, and Texas, are being smuggled in as de minimis parcels, circumventing import duties and regulations. Concerns arise over people buying these medicines from unregulated sources abroad due to potential health risks. The FDA is investigating the influx of counterfeit Ozempic, with manufacturers acknowledging the involvement of organized crime. CBP and FDA are working together to identify illicit medications and ensure consumer safety amidst the rise in counterfeit pharmaceuticals entering the U.S. through international mail facilities.
Source: YAHOO